Clinical Trial Update: Lopinavir (LPV) Dose Reduction [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update examining dose reduction of Lopinavir (LPV) in HIV-1 infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lopinavir (lopinavir)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV-1 Infections | Phase 1, Phase 2 | Status: COMPLETED